Mainz, November 26, 2014 – “In the lecture series “University in the City Hall,” scientists of the Mainz University Medical Center will present a range of current research topics to the general public. In addition to looking at how research is transformed into clinical application, they will also be outlining concepts for innovative future treatments.”
Mainz, December 3, 2014 – “New preclinical test system for an improved analysis of monoclonal antibody function” with Prof. Dr. Ulrich Kalinke – TWINCORE, Hannover, Germany
Mainz, Germany, October 31, 2014 – Translational Medicine: Transforming research achievements into innovative therapeutic and diagnostic products The translation of biomedical research into effective therapeutics and diagnostics is the driving factor for innovation in the pharmaceutical industry.
Mainz, October 23, 2014 – “Image-Guided Drug Delivery” with Dr. Twan Lammers – Helmholtz Center for Biomedical Engineering, Aachen
Mainz, October 16, 2014 – Cancer is a disease caused by DNA mutations. 95% of the mutations in a tumor are unique to that single patient and only a small number of mutations are shared between patients. Therefore, a mutation-targeting individualized therapy would benefit each single patient. In the recent edition of the British Journal of
Mainz, September 30, 2014 – On October 2, Dr. Javad Aman, will give a guest lecture on the clinical development of a vaccine for Ebola. The 1 p.m. lecture at Building 708, at University Medical Center Mainz takes place as part of the TRON Seminar Series in Translational Oncology.
Mainz, Germany, September 23, 2014 – A new review article by TRON director Ugur Sahin provides a comprehensive overview of the current state of mRNA-based drug technologies and their applications, and discusses the key challenges and opportunities in developing these into a new class of drugs.
Mainz, September 15, 2014 – Cancer cell lines are a tremendous resource for cancer biology and therapy development. In a new research paper in the September issue of OncoImmunology, TRON scientists determined the HLA type and HLA expression of 167 cancer and 10 non-cancer cell lines frequently used for the identification of novel tumor targets and
Mainz, September 18, 2014 – “Personalization of cancer therapy” with Prof. Hans Lehrach – Max Planck Institute for Molecular Genetics, Berlin
Mainz, September 03, 2014 – On September 14, TRON researcher Dr. Sebastian Kreiter will explain cancer immunotherapy in a 20-minute presentation aimed at the general public. Dr. Kreiter will speak as part of the Mainz Science Fair in downtown Mainz. On two days, 300 scientists from more than 35 research institutes will present their work,
The September 4 seminar “New preclinical test systems for an improved analysis of monoclonal antibody function” with Prof. Dr. Ulrich Kalinke Executive Director of TWINCORE, Centre for Experimental and Clinical Infection Research, has been cancelled.
Mainz, August 20, 2014 – “Personalized therapies for lung cancer treatment: a paradigm shift in systematical cancer therapy” with Prof. Dr. med. Jürgen Wolf Center for Integrated Oncology at the University Hospital Cologne and Prof. Dr. med. Reinhard Büttner University of Cologne/ Targos GmbH